Annual ROE
-96.62%
-41.98%-76.83%
December 31, 2023
Summary
- As of February 8, 2025, ENLV annual return on equity is -96.62%, with the most recent change of -41.98% (-76.83%) on December 31, 2023.
- During the last 3 years, ENLV annual ROE has fallen by -63.30% (-189.98%).
- ENLV annual ROE is now -468.02% below its all-time high of -17.01%, reached on December 31, 2021.
Performance
ENLV ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-67.57%
+4.19%+5.84%
September 30, 2024
Summary
- As of February 8, 2025, ENLV quarterly return on equity is -67.57%, with the most recent change of +4.19% (+5.84%) on September 30, 2024.
- Over the past year, ENLV quarterly ROE has dropped by -10.55% (-18.50%).
- ENLV quarterly ROE is now -841.71% below its all-time high of 9.11%, reached on September 30, 2018.
Performance
ENLV Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ENLV ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -76.8% | -18.5% |
| 3 y3 years | -190.0% | -34.4% |
| 5 y5 years | -121.1% | -34.4% |
ENLV ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -468.0% | at low | -313.3% | +9.0% |
| 5 y | 5-year | -468.0% | at low | -313.3% | +9.0% |
| alltime | all time | -468.0% | +85.2% | -841.7% | +93.3% |
Enlivex Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -67.57%(-5.8%) |
| Jun 2024 | - | -71.76%(-3.3%) |
| Mar 2024 | - | -74.23%(+4.5%) |
| Dec 2023 | -96.62%(+76.8%) | -71.00%(+24.5%) |
| Sep 2023 | - | -57.02%(+13.8%) |
| Jun 2023 | - | -50.10%(-0.3%) |
| Mar 2023 | - | -50.26%(+7.7%) |
| Dec 2022 | -54.64%(+221.2%) | -46.66%(+20.1%) |
| Sep 2022 | - | -38.86%(+17.9%) |
| Jun 2022 | - | -32.95%(+44.1%) |
| Mar 2022 | - | -22.87%(+39.9%) |
| Dec 2021 | -17.01%(-48.9%) | -16.35%(-20.2%) |
| Sep 2021 | - | -20.50%(-12.2%) |
| Jun 2021 | - | -23.36%(-24.2%) |
| Mar 2021 | - | -30.80%(-17.8%) |
| Dec 2020 | -33.32%(-59.9%) | -37.47%(+8.3%) |
| Sep 2020 | - | -34.60%(-16.9%) |
| Jun 2020 | - | -41.66%(+0.5%) |
| Mar 2020 | - | -41.46%(-40.5%) |
| Dec 2019 | -83.18% | -69.66%(+12.4%) |
| Sep 2019 | - | -61.96%(+16.8%) |
| Jun 2019 | - | -53.06%(-25.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -71.39%(-5.2%) |
| Dec 2018 | -43.70%(-44.8%) | -75.32%(-926.8%) |
| Sep 2018 | - | 9.11%(+4.5%) |
| Jun 2018 | - | 8.72%(-139.5%) |
| Mar 2018 | - | -22.08%(-60.5%) |
| Dec 2017 | -79.16%(-57.0%) | -55.94%(-61.2%) |
| Sep 2017 | - | -144.21%(-7.1%) |
| Jun 2017 | - | -155.16%(+15.1%) |
| Mar 2017 | - | -134.85%(+17.3%) |
| Dec 2016 | -184.18%(+115.0%) | -114.98%(+5.0%) |
| Sep 2016 | - | -109.46%(+24.4%) |
| Jun 2016 | - | -88.02%(+12.7%) |
| Mar 2016 | - | -78.08%(+18.5%) |
| Dec 2015 | -85.68%(+274.3%) | -65.90%(+27.6%) |
| Sep 2015 | - | -51.65%(+23.7%) |
| Jun 2015 | - | -41.77%(+3.6%) |
| Mar 2015 | - | -40.33%(+29.9%) |
| Dec 2014 | -22.89%(-96.5%) | -31.04%(-16.8%) |
| Sep 2014 | - | -37.31%(-72.8%) |
| Jun 2014 | - | -137.37%(-86.3%) |
| Mar 2014 | - | -1001.14%(+58.3%) |
| Dec 2013 | -654.29%(+114.3%) | -632.57% |
| Dec 2012 | -305.33% | - |
FAQ
- What is Enlivex Therapeutics annual return on equity?
- What is the all time high annual ROE for Enlivex Therapeutics?
- What is Enlivex Therapeutics annual ROE year-on-year change?
- What is Enlivex Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Enlivex Therapeutics?
- What is Enlivex Therapeutics quarterly ROE year-on-year change?
What is Enlivex Therapeutics annual return on equity?
The current annual ROE of ENLV is -96.62%
What is the all time high annual ROE for Enlivex Therapeutics?
Enlivex Therapeutics all-time high annual return on equity is -17.01%
What is Enlivex Therapeutics annual ROE year-on-year change?
Over the past year, ENLV annual return on equity has changed by -41.98% (-76.83%)
What is Enlivex Therapeutics quarterly return on equity?
The current quarterly ROE of ENLV is -67.57%
What is the all time high quarterly ROE for Enlivex Therapeutics?
Enlivex Therapeutics all-time high quarterly return on equity is 9.11%
What is Enlivex Therapeutics quarterly ROE year-on-year change?
Over the past year, ENLV quarterly return on equity has changed by -10.55% (-18.50%)